[VRDN] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
11-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -25.31%
YoY- -153.08%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 828 372 4,784 462 818 645 1,091 -4.48%
PBT -8,044 -11,629 -4,661 -6,980 -2,758 -2,634 -706 49.95%
Tax 27 339 167 30 0 0 0 -
NP -8,044 -11,629 -4,661 -6,980 -2,758 -2,634 -706 49.95%
Tax Rate - - - - - - - -
Total Cost 8,872 12,001 9,445 7,442 3,576 3,279 1,797 30.45%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -971.50 -3,126.08 -97.43 -1,510.82 -337.16 -408.37 -64.70 57.00%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.65 -5.65 -2.64 -9.06 -3.85 -6.82 -2.80 -0.91%
EPS Diluted -2.65 -5.65 -2.64 -9.06 -3.85 -6.82 -2.80 -0.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.